Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6.

Pituitary adenylate cyclase-activating polypeptide (PACAP) has been reported to decrease ischemic neuronal damage and increase IL-6 secretion in rats. However, the mechanisms underlying neuroprotection are still to be fully elucidated. The present study was designed to investigate the role played by PACAP and IL-6 in mediating neuroprotection after ischemia in a null mouse. Infarct volume, neurological deficits, and cytochrome c in cytoplasm were higher in PACAP(+/-) and PACAP(-/-) mice than in PACAP(+/+) animals after focal ischemia, although the severity of response was ameliorated by the injection of PACAP38. A decrease in mitochondrial bcl-2 was also accentuated in PACAP(+/-) and PACAP(-/-) mice, but the decrease could be prevented by PACAP38 injection. PACAP receptor 1 (PAC1R) immunoreactivity was colocalized with IL-6 immunoreactivity in neurons, although the intensity of IL-6 immunoreactivity in PACAP(+/-) mice was less than that in PACAP(+/+) animals. IL-6 levels increased in response to PACAP38 injection, an effect that was canceled by cotreatment with the PAC1R antagonist. However, unlike in wild-type controls, PACAP38 treatment did not reduce the infarction in IL-6 null mice. To clarify the signaling pathway associated with the activity of PACAP and IL-6, phosphorylated STAT (signal transducer and activator of transcription) 3, ERK (extracellular signal-regulated kinase), and AKT levels were examined in PACAP(+/-) and IL-6 null mice after ischemia. Lower levels of pSTAT3 and pERK were observed in the PACAP(+/-) mice, whereas a reduction in pSTAT3 was recorded in the IL-6 null mice. These results suggest that PACAP prevents neuronal cell death after ischemia via a signaling mechanism involving IL-6.

[1]  R. Brinton,et al.  17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection , 2005, Neuroscience.

[2]  Wei Zhang,et al.  Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. , 2005, The American journal of pathology.

[3]  H. Okano,et al.  Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons , 2005, Journal of neurochemistry.

[4]  Kortaro Tanaka,et al.  Activation of Cytokine Signaling through Leukemia Inhibitory Factor Receptor (LIFR)/gp130 Attenuates Ischemic Brain Injury in Rats , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  H. Hashimoto,et al.  Neuroprotective action of endogenous PACAP in cultured rat cortical neurons , 2005, Regulatory Peptides.

[6]  S. Shioda,et al.  Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content—Treatment in central nervous system of mice , 2004, Regulatory Peptides.

[7]  H. Vaudry,et al.  Opposite regulation of the mitochondrial apoptotic pathway by C2‐ceramide and PACAP through a MAP‐kinase‐dependent mechanism in cerebellar granule cells , 2004, Journal of neurochemistry.

[8]  P. Chan.  Mitochondria and Neuronal Death/Survival Signaling Pathways in Cerebral Ischemia , 2004, Neurochemical Research.

[9]  Y. Tamura,et al.  The phosphorylation status and anti‐apoptotic activity of Bcl‐2 are regulated by ERK and protein phosphatase 2A on the mitochondria , 2004, FEBS letters.

[10]  S. Bauer,et al.  Somatic and axonal effects of ATP via P2X2 but not P2X7 receptors in rat thoracolumbar sympathetic neurones , 2004, Journal of neurochemistry.

[11]  P. Hoffman,et al.  Phosphatidylinositol 3′‐OH kinase and protein kinase A pathways mediate the anti‐apoptotic effect of pituitary adenylyl cyclase‐activating polypeptide in cultured cerebellar granule neurons: modulation by ethanol , 2003, Journal of neurochemistry.

[12]  S. Shioda,et al.  Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. , 2003, Brain research. Molecular brain research.

[13]  H. Vaudry,et al.  Pituitary adenylate cyclase‐activating polypeptide prevents C2‐ceramide‐induced apoptosis of cerebellar granule cells , 2003, Journal of neuroscience research.

[14]  C. Nitsch,et al.  Interleukin-6 receptor expression and localization after transient global ischemia in gerbil hippocampus , 2003, Neuroscience Letters.

[15]  H. Monyer,et al.  Regulation of Body Temperature and Neuroprotection by Endogenous Interleukin-6 in Cerebral Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  S. Shioda,et al.  Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1 , 2003, Neuroscience Research.

[17]  A. Tamas,et al.  Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia , 2002, Peptides.

[18]  S. Shioda,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways , 2002, Regulatory Peptides.

[19]  S. Onoue,et al.  The neuropeptide PACAP attenuates β-amyloid (1–42)-induced toxicity in PC12 cells , 2002, Peptides.

[20]  S. Onoue,et al.  PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106–126 , 2002, FEBS letters.

[21]  M. Delgado,et al.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[22]  H. Vaudry,et al.  PACAP protects cerebellar granule neurons against oxidative stress‐induced apoptosis , 2002, The European journal of neuroscience.

[23]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Delgado,et al.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Miyazaki,et al.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. Block,et al.  Interleukin-6 expression in exo-focal neurons after striatal cerebral ischemia , 2001, Neuroreport.

[27]  A. García-Osta,et al.  BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons , 2001, Neuroreport.

[28]  D. Reglodi,et al.  Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. , 2000, Stroke.

[29]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[30]  Shigeomi Shimizu,et al.  Bcl‐2 family: Life‐or‐death switch , 2000, FEBS letters.

[31]  L. Lindén.  PACAPs-potential for bronchodilation. , 1999, Pulmonary pharmacology & therapeutics.

[32]  L. Overbergh,et al.  Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. , 1999, Cytokine.

[33]  E. Nagata,et al.  Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils , 1999, Neuroscience Letters.

[34]  S. Shioda,et al.  PACAP Protects Hippocampal Neurons against Apoptosis: Involvement of JNK/SAPK Signaling Pathway a , 1998, Annals of the New York Academy of Sciences.

[35]  A. Arimura.  Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. , 1998, The Japanese journal of physiology.

[36]  S. Shioda,et al.  Immunohistochemical localization of leptin receptor in the rat brain , 1998, Neuroscience Letters.

[37]  N. Rothwell,et al.  Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  W. Banks,et al.  Transport of Pituitary Adenylate Cyclase‐Activating Polypeptide Across the Blood‐Brain Barrier and the Prevention of Ischemia‐Induced Death of Hippocampal Neurons , 1996, Annals of the New York Academy of Sciences.

[39]  W. Banks,et al.  Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide , 1996, Brain Research.

[40]  M. Moskowitz,et al.  Reduced Brain Edema and Infarction Volume in Mice Lacking the Neuronal Isoform of Nitric Oxide Synthase after Transient MCA Occlusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[42]  I. Tatsuno,et al.  Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP) , 1994, Brain Research.

[43]  W. Banks,et al.  Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. , 1993, The Journal of pharmacology and experimental therapeutics.

[44]  K. Nokihara,et al.  Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs , 1993, Peptides.

[45]  K. Mizuno,et al.  Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. , 1991, Endocrinology.

[46]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[47]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[48]  T. Kishimoto.  Interleukin-6: from basic science to medicine--40 years in immunology. , 2005, Annual review of immunology.

[49]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide , 2003, Endocrine Updates.

[50]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[51]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.